Cite
HARVARD Citation
Murray, B. et al. (n.d.). OnabotulinumtoxinA, Nerve Stimulation Devices, Mirabegron, and Anticholinergics Versus Best Supportive Care for Overactive Bladder: An Updated US Cost-Effectiveness Analysis. Toxicon. pp. S43-S44. [Online].